Press releaseGlobe Newswire
Xilio Therapeutics
XLO · NASDAQ
$8.54+$0.21 (+2.52%)TodayMarket closed ·
Prev close $8.33
Latest news
- Press releaseGlobe Newswire
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
- Press releaseGlobe Newswire
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
- Press releaseGlobe Newswire
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
- Press releaseGlobe Newswire
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
- Press releaseGlobe Newswire
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
- News
Xilio Therapeutics Q4 EPS $0.81 Beats $(0.12) Estimate, Sales $13.686M Beat $7.960M Estimate
- Press releaseGlobe Newswire
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
- NewsAvi Kapoor
Why Playboy Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
- Press releaseGlobe Newswire
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
- Press releaseGlobe Newswire
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsAvi Kapoor
Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May
- NewsAvi Kapoor
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results
- Press releaseGlobe Newswire
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
- NewsAvi Kapoor
Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings
- NewsVandana Singh
Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
- NewsAvi Kapoor
Dow Dips Over 300 Points; US Inflation Increases More Than Expected
- Press releaseGlobe Newswire
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
- Press releasePRNewswire
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
- Press releasePRNewswire
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.